Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer

Vivian Wai Yan Lui, Noah D. Peyser, Patrick Kwok Shing Ng, Jozef Hritz, Yan Zeng, Yiling Lu, Hua Li, Lin Wang, Breean R. Gilbert, Ignacio J. General, Ivet Bahar, Zhenlin Ju, Zhenghe Wang, Kelsey P. Pendleton, Xiao Xiao, Yu Du, John K. Vries, Peter S. Hammerman, Levi A. Garraway, Gordon MillsDaniel E. Johnson, Jennifer R. Grandis

Research output: Contribution to journalArticle

48 Citations (Scopus)

Abstract

The underpinnings of STAT3 hyperphosphorylation resulting in enhanced signaling and cancer progression are incompletely understood. Loss-of-function mutations of enzymes that dephosphorylate STAT3, such as receptor protein tyrosine phosphatases, which are encoded by the PTPR gene family, represent a plausible mechanism of STAT3 hyperactivation. We analyzed whole exome sequencing (n = 374) and reverse-phase protein array data (n = 212) from head and neck squamous cell carcinomas (HNSCCs). PTPR mutations are most common and are associated with significantly increased phospho-STAT3 expression in HNSCC tumors. Expression of receptor-like protein tyrosine phosphatase T (PTPRT) mutant proteins induces STAT3 phosphorylation and cell survival, consistent with a "driver" phenotype. Computational modeling reveals functional consequences of PTPRT mutations on phospho-tyrosinesubstrate interactions. A high mutation rate (30%) of PTPRs was found in HNSCC and 14 other solid tumors, suggesting that PTPR alterations, in particular PTPRT mutations, may define a subset of patients where STAT3 pathway inhibitors hold particular promise as effective therapeutic agents.

Original languageEnglish (US)
Pages (from-to)1114-1119
Number of pages6
JournalProceedings of the National Academy of Sciences of the United States of America
Volume111
Issue number3
DOIs
StatePublished - Jan 21 2014
Externally publishedYes

Fingerprint

Protein Tyrosine Phosphatases
Head and Neck Neoplasms
Mutation
Receptor-Like Protein Tyrosine Phosphatases
Exome
Neoplasms
Protein Array Analysis
Mutation Rate
Mutant Proteins
Cell Survival
Phosphorylation
Phenotype
Enzymes
Genes
Carcinoma, squamous cell of head and neck
Therapeutics

Keywords

  • Driver mutations
  • Phosphatase mutations
  • Stat3 activation

ASJC Scopus subject areas

  • General

Cite this

Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer. / Lui, Vivian Wai Yan; Peyser, Noah D.; Ng, Patrick Kwok Shing; Hritz, Jozef; Zeng, Yan; Lu, Yiling; Li, Hua; Wang, Lin; Gilbert, Breean R.; General, Ignacio J.; Bahar, Ivet; Ju, Zhenlin; Wang, Zhenghe; Pendleton, Kelsey P.; Xiao, Xiao; Du, Yu; Vries, John K.; Hammerman, Peter S.; Garraway, Levi A.; Mills, Gordon; Johnson, Daniel E.; Grandis, Jennifer R.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 111, No. 3, 21.01.2014, p. 1114-1119.

Research output: Contribution to journalArticle

Lui, VWY, Peyser, ND, Ng, PKS, Hritz, J, Zeng, Y, Lu, Y, Li, H, Wang, L, Gilbert, BR, General, IJ, Bahar, I, Ju, Z, Wang, Z, Pendleton, KP, Xiao, X, Du, Y, Vries, JK, Hammerman, PS, Garraway, LA, Mills, G, Johnson, DE & Grandis, JR 2014, 'Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer', Proceedings of the National Academy of Sciences of the United States of America, vol. 111, no. 3, pp. 1114-1119. https://doi.org/10.1073/pnas.1319551111/-/DCSupplemental
Lui, Vivian Wai Yan ; Peyser, Noah D. ; Ng, Patrick Kwok Shing ; Hritz, Jozef ; Zeng, Yan ; Lu, Yiling ; Li, Hua ; Wang, Lin ; Gilbert, Breean R. ; General, Ignacio J. ; Bahar, Ivet ; Ju, Zhenlin ; Wang, Zhenghe ; Pendleton, Kelsey P. ; Xiao, Xiao ; Du, Yu ; Vries, John K. ; Hammerman, Peter S. ; Garraway, Levi A. ; Mills, Gordon ; Johnson, Daniel E. ; Grandis, Jennifer R. / Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer. In: Proceedings of the National Academy of Sciences of the United States of America. 2014 ; Vol. 111, No. 3. pp. 1114-1119.
@article{da57b40a34ab4a468159f5bd6eef2699,
title = "Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer",
abstract = "The underpinnings of STAT3 hyperphosphorylation resulting in enhanced signaling and cancer progression are incompletely understood. Loss-of-function mutations of enzymes that dephosphorylate STAT3, such as receptor protein tyrosine phosphatases, which are encoded by the PTPR gene family, represent a plausible mechanism of STAT3 hyperactivation. We analyzed whole exome sequencing (n = 374) and reverse-phase protein array data (n = 212) from head and neck squamous cell carcinomas (HNSCCs). PTPR mutations are most common and are associated with significantly increased phospho-STAT3 expression in HNSCC tumors. Expression of receptor-like protein tyrosine phosphatase T (PTPRT) mutant proteins induces STAT3 phosphorylation and cell survival, consistent with a {"}driver{"} phenotype. Computational modeling reveals functional consequences of PTPRT mutations on phospho-tyrosinesubstrate interactions. A high mutation rate (30{\%}) of PTPRs was found in HNSCC and 14 other solid tumors, suggesting that PTPR alterations, in particular PTPRT mutations, may define a subset of patients where STAT3 pathway inhibitors hold particular promise as effective therapeutic agents.",
keywords = "Driver mutations, Phosphatase mutations, Stat3 activation",
author = "Lui, {Vivian Wai Yan} and Peyser, {Noah D.} and Ng, {Patrick Kwok Shing} and Jozef Hritz and Yan Zeng and Yiling Lu and Hua Li and Lin Wang and Gilbert, {Breean R.} and General, {Ignacio J.} and Ivet Bahar and Zhenlin Ju and Zhenghe Wang and Pendleton, {Kelsey P.} and Xiao Xiao and Yu Du and Vries, {John K.} and Hammerman, {Peter S.} and Garraway, {Levi A.} and Gordon Mills and Johnson, {Daniel E.} and Grandis, {Jennifer R.}",
year = "2014",
month = "1",
day = "21",
doi = "10.1073/pnas.1319551111/-/DCSupplemental",
language = "English (US)",
volume = "111",
pages = "1114--1119",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "3",

}

TY - JOUR

T1 - Frequent mutation of receptor protein tyrosine phosphatases provides a mechanism for STAT3 hyperactivation in head and neck cancer

AU - Lui, Vivian Wai Yan

AU - Peyser, Noah D.

AU - Ng, Patrick Kwok Shing

AU - Hritz, Jozef

AU - Zeng, Yan

AU - Lu, Yiling

AU - Li, Hua

AU - Wang, Lin

AU - Gilbert, Breean R.

AU - General, Ignacio J.

AU - Bahar, Ivet

AU - Ju, Zhenlin

AU - Wang, Zhenghe

AU - Pendleton, Kelsey P.

AU - Xiao, Xiao

AU - Du, Yu

AU - Vries, John K.

AU - Hammerman, Peter S.

AU - Garraway, Levi A.

AU - Mills, Gordon

AU - Johnson, Daniel E.

AU - Grandis, Jennifer R.

PY - 2014/1/21

Y1 - 2014/1/21

N2 - The underpinnings of STAT3 hyperphosphorylation resulting in enhanced signaling and cancer progression are incompletely understood. Loss-of-function mutations of enzymes that dephosphorylate STAT3, such as receptor protein tyrosine phosphatases, which are encoded by the PTPR gene family, represent a plausible mechanism of STAT3 hyperactivation. We analyzed whole exome sequencing (n = 374) and reverse-phase protein array data (n = 212) from head and neck squamous cell carcinomas (HNSCCs). PTPR mutations are most common and are associated with significantly increased phospho-STAT3 expression in HNSCC tumors. Expression of receptor-like protein tyrosine phosphatase T (PTPRT) mutant proteins induces STAT3 phosphorylation and cell survival, consistent with a "driver" phenotype. Computational modeling reveals functional consequences of PTPRT mutations on phospho-tyrosinesubstrate interactions. A high mutation rate (30%) of PTPRs was found in HNSCC and 14 other solid tumors, suggesting that PTPR alterations, in particular PTPRT mutations, may define a subset of patients where STAT3 pathway inhibitors hold particular promise as effective therapeutic agents.

AB - The underpinnings of STAT3 hyperphosphorylation resulting in enhanced signaling and cancer progression are incompletely understood. Loss-of-function mutations of enzymes that dephosphorylate STAT3, such as receptor protein tyrosine phosphatases, which are encoded by the PTPR gene family, represent a plausible mechanism of STAT3 hyperactivation. We analyzed whole exome sequencing (n = 374) and reverse-phase protein array data (n = 212) from head and neck squamous cell carcinomas (HNSCCs). PTPR mutations are most common and are associated with significantly increased phospho-STAT3 expression in HNSCC tumors. Expression of receptor-like protein tyrosine phosphatase T (PTPRT) mutant proteins induces STAT3 phosphorylation and cell survival, consistent with a "driver" phenotype. Computational modeling reveals functional consequences of PTPRT mutations on phospho-tyrosinesubstrate interactions. A high mutation rate (30%) of PTPRs was found in HNSCC and 14 other solid tumors, suggesting that PTPR alterations, in particular PTPRT mutations, may define a subset of patients where STAT3 pathway inhibitors hold particular promise as effective therapeutic agents.

KW - Driver mutations

KW - Phosphatase mutations

KW - Stat3 activation

UR - http://www.scopus.com/inward/record.url?scp=84892928970&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892928970&partnerID=8YFLogxK

U2 - 10.1073/pnas.1319551111/-/DCSupplemental

DO - 10.1073/pnas.1319551111/-/DCSupplemental

M3 - Article

C2 - 24395800

AN - SCOPUS:84892928970

VL - 111

SP - 1114

EP - 1119

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 3

ER -